Home/Filings/4/0001562180-24-006869
4//SEC Filing

Chan Mitchell 4

Accession 0001562180-24-006869

CIK 0001590877other

Filed

Sep 17, 8:00 PM ET

Accepted

Sep 18, 5:04 PM ET

Size

8.0 KB

Accession

0001562180-24-006869

Insider Transaction Report

Form 4
Period: 2024-09-16
Chan Mitchell
Chief Financial Officer
Transactions
  • Award

    Stock Options (Right to buy)

    2024-09-16+289,362289,362 total
    Exercise: $12.74Exp: 2034-09-16Common Stock (289,362 underlying)
  • Award

    Common Stock

    2024-09-16+58,86958,869 total
Footnotes (2)
  • [F1]The restricted stock unit (RSU) award vesting commencement date shall be September 16, 2024. 1/4th of the shares subject to the RSU shall vest on each of the first, second, third and fourth anniversaries of the first day of the month in which the RSU was granted, subject to the continuous service of the recipient to the Issuer.
  • [F2]The option vesting commencement date shall be September 16, 2024. The options shall have a term of 10 years from the date of grant, subject to continuous service of the optionee to the Issuer. The options shall become exercisable as follows: with respect to 1/4th of the shares subject to the option when the optionee completes 12 months of continuous service to the Issuer after the vesting commencement date, and with respect to 1/48th of the shares subject to the option when the optionee completes each month of continuous service to the Issuer thereafter.

Issuer

REGENXBIO Inc.

CIK 0001590877

Entity typeother

Related Parties

1
  • filerCIK 0001789335

Filing Metadata

Form type
4
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 5:04 PM ET
Size
8.0 KB